# Efficacy of Ultrasound Contrast Agent to Assess Renal Masses

> **NCT01062178** · PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 167 (actual)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **DRUG:** Definity

## Key facts

- **NCT ID:** NCT01062178
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2012-10
- **Final completion:** 2012-12
- **Target enrollment:** 167 (ACTUAL)
- **Last updated:** 2016-03-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01062178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01062178, "Efficacy of Ultrasound Contrast Agent to Assess Renal Masses". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01062178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*